IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin.
Ontology highlight
ABSTRACT: Autism spectrum disorder (ASD) does not have a distinct pathogenesis or effective treatment. Increasing evidence supports the presence of immune dysfunction and inflammation in the brains of children with ASD. In this report, we present data that gene expression of the antiinflammatory cytokine IL-37, as well as of the proinflammatory cytokines IL-18 and TNF, is increased in the amygdala and dorsolateral prefrontal cortex of children with ASD as compared to non-ASD controls. Gene expression of IL-18R, which is a receptor for both IL-18 and IL-37, is also increased in the same brain areas of children with ASD. Interestingly, gene expression of the NTR3/sortilin receptor is reduced in the amygdala and dorsolateral prefrontal cortex. Pretreatment of cultured human microglia from normal adult
SUBMITTER: Tsilioni I
PROVIDER: S-EPMC6815178 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA